Stock Rich List
Nasdaq: CHRS

Coherus Oncology insiders

The officers, directors and 10% owners of Coherus Oncology, Inc. who hold the most stock, valued at the live CHRS price.

$0.39
CHRS today −$23K (−5.56%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
2
Their CHRS stock
$23K
Market value
$63.5M
Held by ranked insiders
<0.1%

Insiders by value of CHRS holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Ali J. SatvatDirector30,000$12K<0.1%7082nd
2Rita A. KarachunDirector30,000$12K<0.1%12653rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Coherus Oncology; see each profile for the filing.